Role and rationale for the use of milnacipran in the management of fibromyalgia

QR Code

Role and rationale for the use of milnacipran in the management of fibromyalgia

Jay D Kranzler, R Michael GendreauCypress Bioscence, San Diego, CA, USAAbstract: Fibromyalgia (FM) is a complex syndrome characterized by chronic widespread musculoskeletal pain which is often accompanied by multiple other symptoms, including fatigue, sleep disturbances, decreased physical functioni...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Jay D Kranzler, R Michael Gendreau
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2010
Sujets:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/48dd7cbd79a54dac83bbcdbbaefe92f3
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

New treatment options in the management of fibromyalgia: role of pregabalin
par: Grazyna Zareba
Publié: (2008)

Milnacipran: recent findings in depression
par: Guest editors: Stuart Montgomery (London, et autres
Publié: (2010)

Antidepressant therapy with milnacipran and venlafaxine
par: Lucilla Mansuy
Publié: (2010)

Milnacipran: a unique antidepressant?
par: Siegfried Kasper, et autres
Publié: (2010)

Editorial Foreword - Milnacipran: recent findings in depression
par: Stuart Montgomery, et autres
Publié: (2010)

Usefulness of milnacipran in treating phantom limb pain
par: Matsumoto Y, et autres
Publié: (2012)

Treatment of patients with comorbid depression and diabetes with metformin and milnacipran
par: Peter Hofmann
Publié: (2010)

Improvement of the noradrenergic symptom cluster following treatment with milnacipran
par: Kasper S, et autres
Publié: (2011)

Treatment options and patient perspectives in the management of fibromyalgia: future trends
par: Kim Lawson
Publié: (2008)

Effect of milnacipran on suicidality in patients with mild to moderate depressive disorder
par: Alla Avedisova, et autres
Publié: (2009)

Effects of milnacipran on binge eating &ndash; a pilot study
par: Shun&rsquo;ichi Noma, et autres
Publié: (2008)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression
par: Kamijima K, et autres
Publié: (2013)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression [Corrigendum]
par: Kamijima K, et autres
Publié: (2013)

Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression
par: Hisashi Higuchi,&nbsp;Hitoshi Takahashi, et autres
Publié: (2009)

Effect of triiodothyronine (T3) augmentation of acute milnacipran administration on monoamine levels: an in vivo microdialysis study in rats
par: Kitaichi Y, et autres
Publié: (2012)

New treatment options for fibromyalgia: critical appraisal of duloxetine
par: Nurcan &Uuml;&ccedil;eyler, et autres
Publié: (2008)

Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran
par: Philippe Courtet
Publié: (2010)

Rapid improvement of depressive symptoms in suicide attempters following treatment with milnacipran and tricyclic antidepressants &ndash; a case series
par: Kirino E, et autres
Publié: (2011)

Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group)
par: Heidemarie Abrahamian, et autres
Publié: (2009)

&nbsp;Diabetes mellitus and comorbid depression: improvement of both diseases with milnacipran. A replication study (results of the Austrian Major Depression Diabetes Mellitus study group)
par: Abrahamian H, et autres
Publié: (2012)

Milnacipran and venlafaxine at flexible doses (up to 200 mg/day) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomized, double-blind exploratory study
par: Jean-Pierre Oli&eacute;, et autres
Publié: (2010)

Outcomes analysis of Internet-based CME initiatives for diagnosis and treatment of fibromyalgia patients: transition from education to physician behavior to patient health
par: Somasekhar MM, et autres
Publié: (2012)

Emerging role of sertindole in the management of schizophrenia
par: Stephanie L Cincotta, et autres
Publié: (2010)

Role of oral teriflunomide in the management of multiple sclerosis
par: Tanasescu R, et autres
Publié: (2013)

Role of extended release quetiapine in the management of bipolar disorders
par: Rayan K Al Jurdi, et autres
Publié: (2010)

The role of family therapy in the management of schizophrenia: challenges and solutions
par: Caqueo-Urízar A, et autres
Publié: (2015)

Attention-deficit hyperactivity disorder and impulsivity in female patients with fibromyalgia
par: Yilmaz E, et autres
Publié: (2018)

New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania
par: Warren CG, et autres
Publié: (2013)

New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
par: Bernhard T Baune
Publié: (2008)

Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo&reg;)
par: Paolo Solla, et autres
Publié: (2010)

Sexual dysfunction, mood, anxiety, and personality disorders in female patients with fibromyalgia
par: Kayhan F, et autres
Publié: (2016)

Management of epilepsy in the elderly
par: Juan Jos&eacute; Poza
Publié: (2007)

Management of migraine in adolescents
par: Marielle A Kabbouche, et autres
Publié: (2008)

Pharmacological management of panic disorder
par: Carlo Marchesi
Publié: (2008)

Pregabalin for the management of partial epilepsy
par: Philippe Ryvlin, et autres
Publié: (2008)

Pregabalin in the management of partial epilepsy
par: Amir M Arain
Publié: (2009)

Management of depression in elderly stroke patients
par: Johan L&ouml;kk, et autres
Publié: (2010)

Critical appraisal of lurasidone in the management of schizophrenia
par: Caccia S, et autres
Publié: (2012)

Current management of obsessive and phobic states
par: Goljevscek S, et autres
Publié: (2011)

Role of aripiprazole in treatment-resistant schizophrenia
par: Mossaheb N, et autres
Publié: (2012)